Non-Invasive Ventilation Via a Helmet Device for Patients Respiratory Failure
Study Details
Study Description
Brief Summary
The objective of our study is to evaluate the efficacy of helmet ventilation as compared with Face mask in patients with respiratory failure.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Detailed Description
Respiratory failure is often treated with endotracheal intubation and mechanical ventilation. Although, the institution of mechanical ventilation is considered life saving, the associated complications of tracheal stenosis, ventilator associated pneumonia, barotrauma , and neuromuscular weakness are not without considerable morbidity and mortality.
Non-invasive ventilation has demonstrated significant benefit in patients with hypercapnic respiratory failure from COPD, acute cardiogenic pulmonary edema, and hypoxemic respiratory failure in immunocompromised patients.
Despite the advantages of non-invasive ventilation via facemask, some patients fail because of mask intolerance and severity of disease. Further limitation to facemask non-invasive ventilation is that the seal integrity is lost when higher pressures are required. Unfortunately, certain types of respiratory failure such as that due to hypoxemia or shock may require such higher pressures.
In an attempt to improve patient tolerability and deliver higher pressures, a transparent helmet has been proposed as a novel interface for non-invasive ventilation. It encloses the entire head and neck of the patient. The design of the helmet confers some important advantages: 1) the transparency allows the patient to interact with the environment; 2) the lack of contact to the face lowers the risk of skin necrosis; 3) the helmet avoids problems of leaking with higher airway pressures that are seen with the face mask; 4) it can be applied to any patient regardless of facial contour.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Other: Usual Care Patients who require noninvasive ventilation via Face mask for more than 8 hours will continue using noninvasive ventilation via facemask. |
Other: Noninvasive ventilation via facemask
Patients assigned to the conventional ventilation group will continue noninvasive ventilation via facemask
Other Names:
|
Experimental: Non invasive ventilation via helmet Patients requiring more than 8 hours of noninvasive ventilation via facemask will switch to non-invasive ventilation using a helmet instead of face mask for treatment of respiratory failure |
Device: Non invasive ventilation using a helmet hyperbaric device
Patients randomized to the intervention group will receive noninvasive ventilation delivered via a latex-free helmet connected to the ventilator by conventional tubing.
If endotracheal intubation is required, the helmet will be removed and the patient will be intubated without delay.
Other Names:
|
Outcome Measures
Primary Outcome Measures
- Need for Endotracheal Intubation [6 weeks]
Number of patients requiring endotracheal intubation after application of helmet device
Secondary Outcome Measures
- Hospital Length of Stay [Duration of hospital stay]
Days spent in hospital at time of enrollment
- Number of Participants Functional Status After Discharge [Measured at 1, 6, and 12 months after hospital discharge (to span time frame of up to 80 weeks depending on length of hospitalization)]
Telephone survey of patients 1, 6, and 12 months after discharge to assess need for re-hospitalization, admission to nursing home, and functional status (ability to complete ADLs and IADLs independently)
- Ventilator-free Days [number of days in the hospital]
Duration of mechanical ventilation via endotracheal tube
- Hospital Mortality [90 days]
Death from any cause during hospitalization at time of enrollment
- Intensive Care Unit Length of Stay [4 weeks]
Number of days admitted to a medical intensive care unit
Other Outcome Measures
- ICU Complications [6 weeks]
ICU complications will include rates of Ventilator associated pneumonia, Barotrauma, Gastrointestinal hemorrhage, Pulmonary embolism, Sacral Decubitus ulcer, Delirium, ICU acquired weakness
- Readmission to the Intensive Care Unit [6 weeks]
Measure the need for readmission to the intensive care unit during initial hospitalization at time of enrollment
- Discharge Location [6 weeks]
Measure the location (ie home, rehabilitation center, nursing home) that patients are discharged to
- Improvement of Oxygenation [2 weeks]
Improvement of oxygenation-defined as PaO2/FiO2 ≥ 200 or increase from baseline by 100
Eligibility Criteria
Criteria
Inclusion Criteria:
- Patients aged ≥18 years of age who require noninvasive ventilation via facemask for
8hours
-
Intact airway protective gag reflex
-
Able to follow instructions
Exclusion Criteria:
-
Cardiopulmonary arrest
-
Glasgow coma scale <8
-
Absence of airway protective gag reflex
-
Elevated intracranial pressure
-
Tracheostomy
-
Upper airway obstruction
-
Pregnancy.
-
Patients who refuse to undergo endotracheal intubation, whatever the initial therapeutic approach
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | University of Chicago Medical Center | Chicago | Illinois | United States | 60637 |
Sponsors and Collaborators
- University of Chicago
Investigators
- Principal Investigator: John P Kress, MD, University of Chicago
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 12-1391
Study Results
Participant Flow
Recruitment Details | |
---|---|
Pre-assignment Detail |
Arm/Group Title | Usual Care | Non Invasive Ventilation Via Helmet |
---|---|---|
Arm/Group Description | Patients who require noninvasive ventilation via Face mask for more than 8 hours will continue using noninvasive ventilation via facemask. Noninvasive ventilation via facemask: Patients assigned to the conventional ventilation group will continue noninvasive ventilation via facemask | Patients requiring more than 8 hours of noninvasive ventilation via facemask will switch to non-invasive ventilation using a helmet instead of face mask for treatment of respiratory failure Non invasive ventilation using a helmet hyperbaric device: Patients randomized to the intervention group will receive noninvasive ventilation delivered via a latex-free helmet connected to the ventilator by conventional tubing. If endotracheal intubation is required, the helmet will be removed and the patient will be intubated without delay. |
Period Title: Overall Study | ||
STARTED | 39 | 44 |
COMPLETED | 39 | 44 |
NOT COMPLETED | 0 | 0 |
Baseline Characteristics
Arm/Group Title | Usual Care | Non Invasive Ventilation Via Helmet | Total |
---|---|---|---|
Arm/Group Description | Patients who require noninvasive ventilation via Face mask for more than 8 hours will continue using noninvasive ventilation via facemask. Noninvasive ventilation via facemask: Patients assigned to the conventional ventilation group will continue noninvasive ventilation via facemask | Patients requiring more than 8 hours of noninvasive ventilation via facemask will switch to non-invasive ventilation using a helmet instead of face mask for treatment of respiratory failure Non invasive ventilation using a helmet hyperbaric device: Patients randomized to the intervention group will receive noninvasive ventilation delivered via a latex-free helmet connected to the ventilator by conventional tubing. If endotracheal intubation is required, the helmet will be removed and the patient will be intubated without delay. | Total of all reporting groups |
Overall Participants | 39 | 44 | 83 |
Age (years) [Median (Inter-Quartile Range) ] | |||
Median (Inter-Quartile Range) [years] |
60.9
|
58
|
59
|
Sex: Female, Male (Count of Participants) | |||
Female |
18
46.2%
|
20
45.5%
|
38
45.8%
|
Male |
21
53.8%
|
24
54.5%
|
45
54.2%
|
Race (NIH/OMB) (Count of Participants) | |||
American Indian or Alaska Native |
0
0%
|
0
0%
|
0
0%
|
Asian |
1
2.6%
|
2
4.5%
|
3
3.6%
|
Native Hawaiian or Other Pacific Islander |
0
0%
|
0
0%
|
0
0%
|
Black or African American |
22
56.4%
|
28
63.6%
|
50
60.2%
|
White |
16
41%
|
14
31.8%
|
30
36.1%
|
More than one race |
0
0%
|
0
0%
|
0
0%
|
Unknown or Not Reported |
0
0%
|
0
0%
|
0
0%
|
Outcome Measures
Title | Need for Endotracheal Intubation |
---|---|
Description | Number of patients requiring endotracheal intubation after application of helmet device |
Time Frame | 6 weeks |
Outcome Measure Data
Analysis Population Description |
---|
[Not Specified] |
Arm/Group Title | Usual Care | Non Invasive Ventilation Via Helmet |
---|---|---|
Arm/Group Description | Patients who require noninvasive ventilation via Face mask for more than 8 hours will continue using noninvasive ventilation via facemask. Noninvasive ventilation via facemask: Patients assigned to the conventional ventilation group will continue noninvasive ventilation via facemask | Patients requiring more than 8 hours of noninvasive ventilation via facemask will switch to non-invasive ventilation using a helmet instead of face mask for treatment of respiratory failure Non invasive ventilation using a helmet hyperbaric device: Patients randomized to the intervention group will receive noninvasive ventilation delivered via a latex-free helmet connected to the ventilator by conventional tubing. If endotracheal intubation is required, the helmet will be removed and the patient will be intubated without delay. |
Measure Participants | 39 | 44 |
Count of Participants [Participants] |
24
61.5%
|
8
18.2%
|
Title | Hospital Length of Stay |
---|---|
Description | Days spent in hospital at time of enrollment |
Time Frame | Duration of hospital stay |
Outcome Measure Data
Analysis Population Description |
---|
[Not Specified] |
Arm/Group Title | Usual Care | Non Invasive Ventilation Via Helmet |
---|---|---|
Arm/Group Description | Patients who require noninvasive ventilation via Face mask for more than 8 hours will continue using noninvasive ventilation via facemask. Noninvasive ventilation via facemask: Patients assigned to the conventional ventilation group will continue noninvasive ventilation via facemask | Patients requiring more than 8 hours of noninvasive ventilation via facemask will switch to non-invasive ventilation using a helmet instead of face mask for treatment of respiratory failure Non invasive ventilation using a helmet hyperbaric device: Patients randomized to the intervention group will receive noninvasive ventilation delivered via a latex-free helmet connected to the ventilator by conventional tubing. If endotracheal intubation is required, the helmet will be removed and the patient will be intubated without delay. |
Measure Participants | 39 | 44 |
Median (Inter-Quartile Range) [days] |
15.2
|
10.1
|
Title | Number of Participants Functional Status After Discharge |
---|---|
Description | Telephone survey of patients 1, 6, and 12 months after discharge to assess need for re-hospitalization, admission to nursing home, and functional status (ability to complete ADLs and IADLs independently) |
Time Frame | Measured at 1, 6, and 12 months after hospital discharge (to span time frame of up to 80 weeks depending on length of hospitalization) |
Outcome Measure Data
Analysis Population Description |
---|
[Not Specified] |
Arm/Group Title | Usual Care | Non Invasive Ventilation Via Helmet |
---|---|---|
Arm/Group Description | Patients who require noninvasive ventilation via Face mask for more than 8 hours will continue using noninvasive ventilation via facemask. Noninvasive ventilation via facemask: Patients assigned to the conventional ventilation group will continue noninvasive ventilation via facemask | Patients requiring more than 8 hours of noninvasive ventilation via facemask will switch to non-invasive ventilation using a helmet instead of face mask for treatment of respiratory failure Non invasive ventilation using a helmet hyperbaric device: Patients randomized to the intervention group will receive noninvasive ventilation delivered via a latex-free helmet connected to the ventilator by conventional tubing. If endotracheal intubation is required, the helmet will be removed and the patient will be intubated without delay. |
Measure Participants | 39 | 44 |
Count of Participants [Participants] |
6
15.4%
|
22
50%
|
Title | Ventilator-free Days |
---|---|
Description | Duration of mechanical ventilation via endotracheal tube |
Time Frame | number of days in the hospital |
Outcome Measure Data
Analysis Population Description |
---|
[Not Specified] |
Arm/Group Title | Usual Care | Non Invasive Ventilation Via Helmet |
---|---|---|
Arm/Group Description | Patients who require noninvasive ventilation via Face mask for more than 8 hours will continue using noninvasive ventilation via facemask. Noninvasive ventilation via facemask: Patients assigned to the conventional ventilation group will continue noninvasive ventilation via facemask | Patients requiring more than 8 hours of noninvasive ventilation via facemask will switch to non-invasive ventilation using a helmet instead of face mask for treatment of respiratory failure Non invasive ventilation using a helmet hyperbaric device: Patients randomized to the intervention group will receive noninvasive ventilation delivered via a latex-free helmet connected to the ventilator by conventional tubing. If endotracheal intubation is required, the helmet will be removed and the patient will be intubated without delay. |
Measure Participants | 39 | 44 |
Median (Inter-Quartile Range) [days] |
12.5
|
28
|
Title | Hospital Mortality |
---|---|
Description | Death from any cause during hospitalization at time of enrollment |
Time Frame | 90 days |
Outcome Measure Data
Analysis Population Description |
---|
[Not Specified] |
Arm/Group Title | Usual Care | Non Invasive Ventilation Via Helmet |
---|---|---|
Arm/Group Description | Patients who require noninvasive ventilation via Face mask for more than 8 hours will continue using noninvasive ventilation via facemask. Noninvasive ventilation via facemask: Patients assigned to the conventional ventilation group will continue noninvasive ventilation via facemask | Patients requiring more than 8 hours of noninvasive ventilation via facemask will switch to non-invasive ventilation using a helmet instead of face mask for treatment of respiratory failure Non invasive ventilation using a helmet hyperbaric device: Patients randomized to the intervention group will receive noninvasive ventilation delivered via a latex-free helmet connected to the ventilator by conventional tubing. If endotracheal intubation is required, the helmet will be removed and the patient will be intubated without delay. |
Measure Participants | 39 | 44 |
Count of Participants [Participants] |
19
48.7%
|
12
27.3%
|
Title | Intensive Care Unit Length of Stay |
---|---|
Description | Number of days admitted to a medical intensive care unit |
Time Frame | 4 weeks |
Outcome Measure Data
Analysis Population Description |
---|
[Not Specified] |
Arm/Group Title | Usual Care | Non Invasive Ventilation Via Helmet |
---|---|---|
Arm/Group Description | Patients who require noninvasive ventilation via Face mask for more than 8 hours will continue using noninvasive ventilation via facemask. Noninvasive ventilation via facemask: Patients assigned to the conventional ventilation group will continue noninvasive ventilation via facemask | Patients requiring more than 8 hours of noninvasive ventilation via facemask will switch to non-invasive ventilation using a helmet instead of face mask for treatment of respiratory failure Non invasive ventilation using a helmet hyperbaric device: Patients randomized to the intervention group will receive noninvasive ventilation delivered via a latex-free helmet connected to the ventilator by conventional tubing. If endotracheal intubation is required, the helmet will be removed and the patient will be intubated without delay. |
Measure Participants | 39 | 44 |
Median (Inter-Quartile Range) [days] |
7.8
|
4.7
|
Title | ICU Complications |
---|---|
Description | ICU complications will include rates of Ventilator associated pneumonia, Barotrauma, Gastrointestinal hemorrhage, Pulmonary embolism, Sacral Decubitus ulcer, Delirium, ICU acquired weakness |
Time Frame | 6 weeks |
Outcome Measure Data
Analysis Population Description |
---|
[Not Specified] |
Arm/Group Title |
---|
Arm/Group Description |
Title | Readmission to the Intensive Care Unit |
---|---|
Description | Measure the need for readmission to the intensive care unit during initial hospitalization at time of enrollment |
Time Frame | 6 weeks |
Outcome Measure Data
Analysis Population Description |
---|
[Not Specified] |
Arm/Group Title |
---|
Arm/Group Description |
Title | Discharge Location |
---|---|
Description | Measure the location (ie home, rehabilitation center, nursing home) that patients are discharged to |
Time Frame | 6 weeks |
Outcome Measure Data
Analysis Population Description |
---|
[Not Specified] |
Arm/Group Title |
---|
Arm/Group Description |
Title | Improvement of Oxygenation |
---|---|
Description | Improvement of oxygenation-defined as PaO2/FiO2 ≥ 200 or increase from baseline by 100 |
Time Frame | 2 weeks |
Outcome Measure Data
Analysis Population Description |
---|
[Not Specified] |
Arm/Group Title |
---|
Arm/Group Description |
Adverse Events
Time Frame | 6 months | |||
---|---|---|---|---|
Adverse Event Reporting Description | ||||
Arm/Group Title | Usual Care | Non Invasive Ventilation Via Helmet | ||
Arm/Group Description | Patients who require noninvasive ventilation via Face mask for more than 8 hours will continue using noninvasive ventilation via facemask. Noninvasive ventilation via facemask: Patients assigned to the conventional ventilation group will continue noninvasive ventilation via facemask | Patients requiring more than 8 hours of noninvasive ventilation via facemask will switch to non-invasive ventilation using a helmet instead of face mask for treatment of respiratory failure Non invasive ventilation using a helmet hyperbaric device: Patients randomized to the intervention group will receive noninvasive ventilation delivered via a latex-free helmet connected to the ventilator by conventional tubing. If endotracheal intubation is required, the helmet will be removed and the patient will be intubated without delay. | ||
All Cause Mortality |
||||
Usual Care | Non Invasive Ventilation Via Helmet | |||
Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | |
Total | 22/39 (56.4%) | 12/44 (27.3%) | ||
Serious Adverse Events |
||||
Usual Care | Non Invasive Ventilation Via Helmet | |||
Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | |
Total | 0/39 (0%) | 0/44 (0%) | ||
Other (Not Including Serious) Adverse Events |
||||
Usual Care | Non Invasive Ventilation Via Helmet | |||
Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | |
Total | 0/39 (0%) | 0/44 (0%) |
Limitations/Caveats
More Information
Certain Agreements
Principal Investigators are NOT employed by the organization sponsoring the study.
There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
Results Point of Contact
Name/Title | John P. Kress |
---|---|
Organization | University of Chicago |
Phone | 7737026790 |
jkress@medicine.bsd.uchicago.edu |
- 12-1391